Eduardo Karahanian

Santiago, RM, Chile

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

High intellectual ability and the gut-brain-sex steroids axis: a perspective on cognitive and emotional diversity.

High intellectual ability and the gut-brain-sex steroids axis: a perspective on cognitive and emotional diversity.

Journal: Frontiers in physiology

Published: January 20, 2026

Fenofibrate restores glutamatergic and dopaminergic homeostasis in the nucleus accumbens and reduces alcohol relapse in rats.

Fenofibrate restores glutamatergic and dopaminergic homeostasis in the nucleus accumbens and reduces alcohol relapse in rats.

Journal: Frontiers in pharmacology

Published: January 20, 2026

Long-term region-specific mitochondrial respiration impairment after perinatal asphyxia is prevented by the NAD⁺ donor nicotinamide riboside: A real-time organotypic metabolic profiling approach.

Long-term region-specific mitochondrial respiration impairment after perinatal asphyxia is prevented by the NAD⁺ donor nicotinamide riboside: A real-time organotypic metabolic profiling approach.

Journal: Pharmacological research

Published: January 13, 2026

The Role of Microbiota, Gut Integrity, and Neuroinflammation in Relapse Vulnerability in Alcohol Use Disorder.

The Role of Microbiota, Gut Integrity, and Neuroinflammation in Relapse Vulnerability in Alcohol Use Disorder.

Journal: Current neuropharmacology

Published: October 22, 2025

Fenofibrate treatment during withdrawal reverses symptoms of ethanol-induced depression in male rats.

Fenofibrate treatment during withdrawal reverses symptoms of ethanol-induced depression in male rats.

Journal: Frontiers in pharmacology

Published: May 09, 2025

Reduction of Alcohol-Dependent Lung Pathological Features in Rats Treated with Fenofibrate.

Reduction of Alcohol-Dependent Lung Pathological Features in Rats Treated with Fenofibrate.

Journal: International journal of molecular sciences

Published: October 21, 2024

Fenofibrate Decreases Ethanol-Induced Neuroinflammation and Oxidative Stress and Reduces Alcohol Relapse in Rats by a PPAR-α-Dependent Mechanism.

Fenofibrate Decreases Ethanol-Induced Neuroinflammation and Oxidative Stress and Reduces Alcohol Relapse in Rats by a PPAR-α-Dependent Mechanism.

Journal: Antioxidants (Basel, Switzerland)

Published: August 16, 2023

Alcohol use disorder, neuroinflammation, and intake of dietary fibers: a new approach for treatment.

Alcohol use disorder, neuroinflammation, and intake of dietary fibers: a new approach for treatment.

Journal: The American journal of drug and alcohol abuse

Published: October 04, 2022

Fenofibrate (a PPAR-α Agonist) Administered During Ethanol Withdrawal Reverts Ethanol-Induced Astrogliosis and Restores the Levels of Glutamate Transporter in Ethanol-Administered Adolescent Rats.

Fenofibrate (a PPAR-α Agonist) Administered During Ethanol Withdrawal Reverts Ethanol-Induced Astrogliosis and Restores the Levels of Glutamate Transporter in Ethanol-Administered Adolescent Rats.

Journal: Frontiers in pharmacology

Published: January 13, 2021

Use of Short-Chain Fatty Acids for the Recovery of the Intestinal Epithelial Barrier Affected by Bacterial Toxins.

Use of Short-Chain Fatty Acids for the Recovery of the Intestinal Epithelial Barrier Affected by Bacterial Toxins.

Journal: Frontiers in physiology

Published: January 07, 2021

Activation of Melanocortin-4 Receptor Inhibits Both Neuroinflammation Induced by Early Exposure to Ethanol and Subsequent Voluntary Alcohol Intake in Adulthood in Animal Models: Is BDNF the Key Mediator?

Activation of Melanocortin-4 Receptor Inhibits Both Neuroinflammation Induced by Early Exposure to Ethanol and Subsequent Voluntary Alcohol Intake in Adulthood in Animal Models: Is BDNF the Key Mediator?

Journal: Frontiers in cellular neuroscience

Published: November 28, 2019

Activation of Melanocortin-4 Receptor by a Synthetic Agonist Inhibits Ethanolinduced Neuroinflammation in Rats.

Activation of Melanocortin-4 Receptor by a Synthetic Agonist Inhibits Ethanolinduced Neuroinflammation in Rats.

Journal: Current pharmaceutical design

Published: October 30, 2019

Showing 1-12 of 26

Last Updated: 09/26/2026